Skip to main content
Premium Trial:

Request an Annual Quote

AstraZeneca Opens Boston R&D Center

Premium

Britain’s AstraZeneca has announced the opening of AstraZeneca R&D Boston, the company’s third research facility in North America.

 

The $100 million research center will employ 130 scientists specializing in infectious diseases and cancer. Additional research will focus on high-throughput screening technologies that enable novel, scientific approaches to pharmaceutical research.

 

Scientists at the facility will couple genomics with molecular biology in an effort to identify potential drug targets.

 

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.